Skip to content

A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.

Nutrition, metabolism, and cardiovascular diseases : NMCD
Aug 2015
Citations: 96
Influential: 4
Interventional (Human) Studies
87

What this study found

A plain-language finding is not available for this paper.

Study & population
Interventional (Human) Studies
View source

Original abstract

No abstract is available for this paper.

©2026 Supplement AI Inc.

Supplement AI is available on the web and as Supplement AI: Stack Optimizer on the iOS App Store. It provides evidence-based decision support, not medical advice, diagnosis, or treatment. The only official Supplement AI domain is supplementai.io; we are not affiliated with similarly named apps or services.

Select a display theme